Afshin Dowlati

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Afshin Dowlati

Sep 4, 2024, 06:47 | Insight

Jarushka Naidoo: Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial

Jarushka Naidoo shared on X: "Intracranial activity of Tarlatamab in 2L SCLC in Ph I…

Aug 31, 2024, 20:07 | Insight

5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few…

Aug 22, 2024, 14:54 | Blog

LCC in Farsi: Afshin Dowlati and Sharareh Seifi with Hossein Borghaei

Estela Rodriguez shared a post on X: "Even if I can’t understand Farsi, I can…

Apr 26, 2024, 20:26 | Insight

New Paper Alert! Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial

Liposomal Irinotecan vs Topotecan for Relapsed Small Cell Lung Cancer: RESILIENT Phase 3 Trial Authors:…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023